Abstract | PURPOSE: METHODS AND MATERIALS: Of 72 patients with vaginal cancer treated with brachytherapy (BT), 47 had image guidance (CT=31, MRI=16) and 25 did not. Kaplan-Meier (KM) estimates were generated for any recurrence, local control (LC), disease-free interval (DFI), and overall survival (OS) and Cox models were used to assess prognostic factors. RESULTS: Median age was 66 and median follow-up time was 24months. Median cumulative EQD2 dose was 80.8Gy in the non-IBBT group and 77Gy in the IBBT group. For non-IBBT versus IBBT, the 2-year KM LC was 71% vs. 93% (p=0.03); DFI was 54% vs. 86% (p=0.04); and OS 52% vs. 82% (p=0.35). On multivariate analysis, IBBT was associated with better DFI (HR 0.24, 95% CI 0.07-0.73). Having any 2 or more of chemotherapy, high-dose-rate (HDR) BT or IBBT (temporally correlated variables) significantly reduced risk of relapse (HR=0.33, 95% CI=0.13-0.83), compared to having none of these factors. CONCLUSION:
|
Authors | Matthias M Manuel, Linda P Cho, Paul J Catalano, Antonio L Damato, David T Miyamoto, Clare M Tempany, Ehud J Schmidt, Akila N Viswanathan |
Journal | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
(Radiother Oncol)
Vol. 120
Issue 3
Pg. 486-492
(09 2016)
ISSN: 1879-0887 [Electronic] Ireland |
PMID | 27321150
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Elsevier Ireland Ltd. All rights reserved. |
Topics |
- Aged
- Brachytherapy
(adverse effects, methods)
- Female
- Humans
- Kaplan-Meier Estimate
- Magnetic Resonance Imaging
(methods)
- Middle Aged
- Neoplasm Recurrence, Local
(etiology)
- Neoplasm Staging
- Prognosis
- Radiotherapy Dosage
- Radiotherapy, Image-Guided
(adverse effects, methods)
- Retrospective Studies
- Tomography, X-Ray Computed
(methods)
- Treatment Outcome
- Vaginal Neoplasms
(diagnostic imaging, pathology, radiotherapy)
|